Pharvaris NV () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

638.34 k

Shareholding (Mar 2025)

FII

5.63%

Held by 30 FIIs

DII

29.32%

Held by 17 DIIs

Promoter

52.42%

How big is Pharvaris NV?

22-Jun-2025

As of Jun 18, Pharvaris NV has a market capitalization of 902.41 million, with net sales of 0.00 million and a net profit of -163.68 million over the latest four quarters. Shareholder's funds are 277.27 million, and total assets amount to 301.72 million.

What does Pharvaris NV do?

22-Jun-2025

Pharvaris NV is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $49 million and a market cap of $902.41 million. Key metrics include a negative P/E ratio, no dividend yield, and a return on equity of -67.24%.

Is Pharvaris NV technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Pharvaris NV's technical trend is bullish, supported by positive MACD indicators and moving averages, while it has outperformed the S&P 500 with a year-to-date return of 28.01% compared to 12.22%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 1,398 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.08

Return on Equity

-84.69%

Price to Book

6.46

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-52 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

26.38%

6 Months

60.24%

1 Year

39.99%

2 Years

48.95%

3 Years

1298.48%

4 Years

88.88%

5 Years

0.0%

Pharvaris NV for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Pharvaris NV technically bullish or bearish?

As of 9 September 2025, the technical trend for Pharvaris NV has changed from mildly bullish to bullish. The current stance is bullish, supported by weekly and monthly MACD indicators, which are both bullish, as well as bullish signals from Bollinger Bands and daily moving averages. The KST is bullish on a weekly basis but mildly bearish monthly, while Dow Theory indicates a mildly bullish weekly and mildly bearish monthly outlook. The OBV shows a mildly bullish trend in both time frames. Pharvaris NV has outperformed the S&P 500 across multiple periods, with a year-to-date return of 28.01% compared to the S&P 500's 12.22%, and a three-year return of 169.08% versus 70.41% for the index....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-172.19%

EBIT to Interest (avg)

-117.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.05

Sales to Capital Employed (avg)

Tax Ratio

1.51%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

86.94%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.76

EV to EBIT

-3.85

EV to EBITDA

-3.86

EV to Capital Employed

-55.66

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-67.24%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 9 Schemes (12.62%)

Foreign Institutions

Held by 30 Foreign Institutions (5.63%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -61.25% vs -34.45% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-45.70",
          "val2": "-36.90",
          "chgp": "-23.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-51.60",
          "val2": "-32.00",
          "chgp": "-61.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -33.09% vs -36.03% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-157.30",
          "val2": "-104.50",
          "chgp": "-50.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-145.20",
          "val2": "-109.10",
          "chgp": "-33.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-45.70

-36.90

-23.85%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-51.60

-32.00

-61.25%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -61.25% vs -34.45% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-157.30

-104.50

-50.53%

Interest

0.10

0.00

Exceptional Items

0.00

Consolidate Net Profit

-145.20

-109.10

-33.09%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -33.09% vs -36.03% in Dec 2023

All Annual Results

Company CV

About Pharvaris NV

Pharvaris NV

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Pharvaris NV

1Day

52 Week

CASH

FII

DII

Promoter

How big is Pharvaris NV?

Watch in Real-Time

What does Pharvaris NV do?

Is Pharvaris NV technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Pharvaris NV technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Pharvaris NV

Company Coordinates